Cargando…
On the use of antiangiogenetic medications for retinopathy of prematurity
[Image: see text] In contrast to the adult, the third-trimester foetus experiences one of the most intense periods of growth and maturation of its lifetime. Early development is characterized by the existence of critical periods when environmental factors effectively produce long-lasting changes. Pr...
Autores principales: | Hård, Anna-Lena, Hellström, Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206215/ https://www.ncbi.nlm.nih.gov/pubmed/21517962 http://dx.doi.org/10.1111/j.1651-2227.2011.02330.x |
Ejemplares similares
-
Blood protein profiles related to preterm birth and retinopathy of prematurity
por: Danielsson, Hanna, et al.
Publicado: (2021) -
Screening and surveillance for retinopathy of prematurity: A Wilson and Jungner framework approach
por: Athikarisamy, Sam Ebenezer, et al.
Publicado: (2023) -
Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity
por: Lundgren, Pia, et al.
Publicado: (2017) -
Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer
por: Dalbeni, Andrea, et al.
Publicado: (2018) -
Retinopathy of prematurity: the need for prevention
por: Liegl, Raffael, et al.
Publicado: (2016)